Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.
Fiche du document
26 septembre 2023
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.celrep.2023.113132
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37708024
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2211-1247
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_16A8315649066
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Melanocytic tumor Malignant melanoma Melanin-synthesizing cells Deoxyribonucleic acid TNA (Nucleic acid) Desoxyribonucleic acid Thymonucleic acidCiter ce document
D. Gentien et al., « Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma. », Serveur académique Lausannois, ID : 10.1016/j.celrep.2023.113132
Métriques
Partage / Export
Résumé
Uveal melanoma (UM) is a rare cancer resulting from the transformation of melanocytes in the uveal tract. Integrative analysis has identified four molecular and clinical subsets of UM. To improve our molecular understanding of UM, we performed extensive multi-omics characterization comparing two aggressive UM patient-derived xenograft models with normal choroidal melanocytes, including DNA optical mapping, specific histone modifications, and DNA topology analysis using Hi-C. Our gene expression and cytogenetic analyses suggest that genomic instability is a hallmark of UM. We also identified a recurrent deletion in the BAP1 promoter resulting in loss of expression and associated with high risk of metastases in UM patients. Hi-C revealed chromatin topology changes associated with the upregulation of PRAME, an independent prognostic biomarker in UM, and a potential therapeutic target. Our findings illustrate how multi-omics approaches can improve our understanding of tumorigenesis and reveal two distinct mechanisms of gene expression dysregulation in UM.